Regeneron Pharmaceuticals, Inc. (REGN) SEC filings
REGN SEC filings moved a median of -0.14% by the close. REGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the REGN overview →
35 measured REGN SEC filing events.
Where these REGN SEC filings landedvs 34 measured REGN SEC filing reactions
| Middle 50% of REGN SEC filing reactions | -2.05% to +1.27% |
|---|---|
| Median reaction (to close) | -0.14% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 REGN SEC filing events with a measured close landed between -2.05% and +1.27%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K REGENERON PHARMACEUTICAL For: Oct 01 | SEC filing · Form 8-K | -0.37% | +0.56% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Sep 24 | SEC filing · Form 8-K | +0.81% | -4.14% | |
| Form N-PX REGENERON PHARMACEUTICAL For: Jun 30 | SEC filing · Form N-PX | -0.02% | -0.20% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Jun 30 | SEC filing · Form 13F-HR | +0.95% | — | |
| Form 10-Q REGENERON PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | +0.12% | +5.48% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jul 30 | SEC filing · Form 8-K | +0.12% | +5.48% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jul 06 | SEC filing · Form 8-K | -0.14% | +0.12% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jun 12 | SEC filing · Form 8-K | -0.68% | -0.35% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Mar 31 | SEC filing · Form 13F-HR | +1.54% | -0.31% | |
| Form 10-Q REGENERON PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -0.36% | -2.37% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Apr 29 | SEC filing · Form 8-K | -0.36% | -2.37% | |
| Form ARS REGENERON PHARMACEUTICAL For: Dec 31 | SEC filing · Form ARS | +1.03% | -0.14% | |
| Form DEF 14A REGENERON PHARMACEUTICAL For: Jun 12 | SEC filing · Form DEF | +1.03% | -0.14% | |
| Form DEFA14A REGENERON PHARMACEUTICAL | SEC filing · Form DEFA14A | +1.03% | -0.14% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Apr 08 | SEC filing · Form 8-K | -1.21% | +1.34% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Dec 31 | SEC filing · Form 13F-HR | +0.55% | -0.37% | |
| Form 10-K REGENERON PHARMACEUTICAL For: Dec 31 | SEC filing · Form 10-K | +1.01% | +1.21% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jan 30 | SEC filing · Form 8-K | +0.44% | -1.66% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jan 12 | SEC filing · Form 8-K | -2.50% | -5.18% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Sep 30 | SEC filing · Form 13F-HR | +0.83% | -0.19% | |
| Form 10-Q REGENERON PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | +0.03% | +6.94% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Oct 28 | SEC filing · Form 8-K | +0.03% | +6.94% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Oct 06 | SEC filing · Form 8-K | -0.64% | -2.74% | |
| Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol | Press release | -0.07% | +0.34% | |
| Form 10-Q REGENERON PHARMACEUTICAL For: Jun 30 | SEC filing · Form 10-Q | -1.59% | -4.14% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Jun 30 | SEC filing · Form 13F-HR | +0.53% | +0.80% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Aug 01 | SEC filing · Form 8-K | -1.59% | -4.14% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Jun 13 | SEC filing · Form 8-K | -0.16% | -2.17% | |
| Form 13F-HR REGENERON PHARMACEUTICAL For: Mar 31 | SEC filing · Form 13F-HR | -0.25% | -0.55% | |
| Form 10-Q REGENERON PHARMACEUTICAL For: Mar 31 | SEC filing · Form 10-Q | -1.95% | +1.27% | |
| Form 8-K REGENERON PHARMACEUTICAL For: Apr 29 | SEC filing · Form 8-K | -1.95% | +1.27% | |
| Form ARS REGENERON PHARMACEUTICAL For: Dec 31 | SEC filing · Form ARS | -1.95% | +1.27% | |
| Form DEF 14A REGENERON PHARMACEUTICAL For: Jun 13 | SEC filing · Form DEF | -1.95% | +1.27% | |
| Form DEFA14A REGENERON PHARMACEUTICAL | SEC filing · Form DEFA14A | -1.95% | +1.27% | |
| Form PRE 14A REGENERON PHARMACEUTICAL For: Jun 13 | SEC filing · Form PRE | -0.05% | -3.91% |
Keep exploring
More REGN: earnings → · analyst actions → · REGN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DexCom, Inc. (DXCM) | 2,000+ | +0.04% | 51% |
| Endo International plc - Ordinary Shares (ENDP) | 2,000+ | 0.00% | 49% |
| Novo Nordisk A/S (NVO) | 1,909 | 0.00% | 50% |
| CELGENE (CELG) | 1,880 | +0.03% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.